Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Other ICR Research
  • View item
  • Home
  • ICR Divisions
  • Other ICR Research
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated Gliomas

Thumbnail
Date
2016-09
ICR Author
Labreche, Karim
Type
Journal Article
Metadata
Show full item record
Abstract
Background. The 1p19q non-codeleted gliomas with IDH mutation, defined as "molecular astrocytomas," display frequent TP53 mutations and have an intermediate prognosis. We investigated the prognostic impact of copy number-neutral loss of heterozygosity (CNLOH) in 17p in this population. Methods. We analyzed 793 gliomas (206 grade II, 377 grade III, and 210 grade IV) by single nucleotide polymorphism array and for TP53 mutations. Results. Homodisomy revealed by CNLOH was observed in 156 cases (19.7%). It was more frequent in astrocytomas and oligoastrocytomas (98/256, 38%) than oligodendrogliomas (28/327, 8.6%; p<.0001) or glioblastoma multiforme (30/210, 14.3%; p<.0001), tightly associated with TP53 mutation (69/71 vs. 20/79; p = 2 x 10(-16)), and mutually exclusive with 1p19q codeletion (1/156 vs. 249/556; p<. 0001). In the group of IDH-mutated 1p19q non-codeleted gliomas, CNLOH 17p was associated with longer survival (86.3 vs. 46.2 months; p=.004), particularly in grade III gliomas (overall survival >100 vs. 37.9 months; p=.007). These data were confirmed in an independent dataset from the Cancer Genome Atlas. Conclusion. CNLOH 17p is a prognostic marker and further refines the molecular classification of gliomas.
URI
https://repository.icr.ac.uk/handle/internal/1843
Collections
  • Other ICR Research
Subject
Gliomas Copy number neutral loss of heterozygosity TP53 mutation MYELOID MALIGNANCIES TP53 MUTATIONS NEUTRAL LOSS COPY HETEROZYGOSITY TUMORS
Language
eng
License start date
2016-09
Citation
ONCOLOGIST, 2016, 21 (9), pp. 1131 - 1135

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.